Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 645Pancreatic Neoplasms 392Carcinoma, Hepatocellular 308Stomach Neoplasms 252Rectal Neoplasms 182Colonic Neoplasms 182Esophageal Neoplasms 171Carcinoma, Non-Small-Cell Lung 169Breast Neoplasms 150Neoplasms 135Neoplasm Metastasis 131Ovarian Neoplasms 123Cholangiocarcinoma 112Lung Neoplasms 108Liver Neoplasms 107Gastrointestinal Neoplasms 98Melanoma 87Biliary Tract Neoplasms 77Prostatic Neoplasms 75Endometrial Neoplasms 74Esophageal Squamous Cell Carcinoma 67Carcinoma, Renal Cell 57Squamous Cell Carcinoma of Head and Neck 54Sarcoma 54Uterine Cervical Neoplasms 51Adenocarcinoma Of Esophagus 47Head and Neck Neoplasms 46Urinary Bladder Neoplasms 42Triple Negative Breast Neoplasms 39Anus Neoplasms 36

Interventions

Panitumumab 1IFL protocol 1Gemcitabine 1Cetuximab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis × Gastrointestinal × 90 days × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡